ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 053040 | 3-year financial timeline | COVID resilience: 64/100
🛡️ Public data only — no PHI permitted on this instance.
$23M
Latest Revenue (FY2022)
+6.3%
Revenue CAGR (3yr)
1.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $20M | $22M | $23M | +4.7% | +6.3% |
| Operating Expenses | $21M | $22M | $23M | +4.9% | +4.6% |
| Operating Margin | -1.6% | 1.8% | 1.7% | -7.0% | +0.0% |
| Net Income | $-0M | $0M | $0M | -2.6% | +0.0% |
| Licensed Beds | 50 | 50 | 50 | +0.0% | +0.0% |
| Total Patient Days | 11,456 | 12,252 | 12,260 | +0.1% | +3.4% |
| Medicare Day % | 55% | 50% | 53% | +5.9% | -1.9% |
| Medicaid Day % | 4% | 5% | 5% | -1.5% | +7.6% |
COVID Impact & Recovery
Resilience Score: 64/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +13.1% ($20M → $23M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.3%
This Hospital
+7.6%
State Avg
Latest Margin
1.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $24M | 3.3% |
| FY2024 (proj) | $26M | 5.0% |
| FY2025 (proj) | $27M | 6.6% |